Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two hormones in the gut that help regulate blood sugar, reduce hunger cues and slow digestion. It’s the active ingredient in the ...

Add Yahoo as a preferred source to see more of our stories on Google. Compound drugs are copies of U.S. Food and Drug Administration-approved medications. They are made by licensed pharmacies, but not ...

Demand for popular weight loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) has long outpaced supply, forcing many patients with obesity to visit compounding pharmacies to get ...

Compounded tirzepatide contains the same active ingredient as Mounjaro but may differ in quality, ingredients, and dosage. The Food and Drug Administration (FDA) does not regulate its safety, ...

Tirzepatide (Zepbound) is not in shortage for now, but the weight loss drug has remained inaccessible to people without insurance coverage who can't afford to pay out of pocket. Now, its manufacturer, ...

Compounding pharmacies were largely supposed to stop making versions of tirzepatide this week, but it's still available on some popular websites like Amble, EllieMD, Willow and Mochi Health.

The Food and Drug Administration said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide — the active ingredient in Eli Lilly’s ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...

Not only celebrities are increasingly turning to the so-called “weight loss injection” to shed pounds. Now, two studies show that there are differences in the effectiveness of various providers. A ...

Using medications for weight loss is becoming more common. Doctors sometimes prescribe newer type 2 diabetes drugs to help with weight management. This use is “off-label,” meaning that doctors ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...